Piperidin-1-ylmethyl-phosphonic acid dimethyl ester | 89435-69-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机膦酸及其衍生物
• 英文名称: Piperidin-1-ylmethyl-phosphonic acid dimethyl ester
• 英文别名: Phosphonic acid, (1-piperidinylmethyl)-, dimethyl ester；1-(dimethoxyphosphorylmethyl)piperidine
• CAS: 89435-69-8
• 化学式: C₈H₁₈NO₃P
• 分子量: 207.21
• InChiKey: QMXOQAZEAMBIAD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  1-(甲氧基甲基)哌啶 在 甲醇 、 phosphorus 、 sodium methylate 作用下， 以0.4 g的产率得到tris(N-piperidinomethyl)phosphine oxide
  参考文献：
  名称：

  Reaction of Elemental (White) Phosphorus with (Alkoxymethyl)dialkylamines

  摘要：

  The reaction of elemental (white) phosphorus with (alkoxymethyl)dialkylamines in the presence of sodium alkoxide results in complete conversion of P-4 in proton-donor solvents only. P-31 NMR spectroscopy allowed detection of the initial formation of P-III compounds whose subsequent transformations primarily provide phosphinate and phosphonate structures. Under the reaction conditions, trialkyl phosphites further react with (alkoxymethyl)dialkylamines to form dialkyl (dialkylamino)methylphosphonates.

  DOI：

  10.1023/b:rugc.0000015981.21117.9f

文献信息

• [EN] INHIBITORS OF INFLUENZA VIRUSES REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DES VIRUS DE LA GRIPPE
  申请人：VERTEX PHARMA

  公开号：WO2010148197A1

  公开（公告）日：2010-12-23

  Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

  抑制生物样本或患者中流感病毒复制的方法，减少生物样本或患者中流感病毒数量的方法，以及治疗患者流感的方法，包括向所述生物样本或患者中投与有效量的化合物，该化合物由结构式（I）表示或其药学上可接受的盐，其中结构式（IA）的值如此处所述。该化合物由结构式（IA）表示或其药学上可接受的盐，其中结构式（IA）的值如此处所述。一种药物组合物包括有效量的该化合物或其药学上可接受的盐，以及药学上可接受的载体、佐剂或溶剂。
• INHIBITORS OF INFLUENZA VIRUSES REPLICATION
  申请人：Vertex Pharmaceuticals Inc.

  公开号：EP3141252A1

  公开（公告）日：2017-03-15

  Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

  抑制生物样本或患者体内流感病毒复制、减少生物样本或患者体内流感病毒数量以及治疗患者流感的方法，包括向所述生物样本或患者施用有效量的结构式（I）所代表的化合物： 或其药学上可接受的盐，其中结构式（IA）的值如本文所述。一种化合物由结构式（IA）或其药学上可接受的盐代表，其中结构式（IA）的值如本文所述。药物组合物包含有效量的此类化合物或其药学上可接受的盐，以及药学上可接受的载体、佐剂或载体。
• Synthesis and Acid-Base Properties of  -Aminophosphoryl Compounds
  作者：S. V. Zakharov、G. Kh. Nuriazdanova、A. R. Garifzyanov、V. I. Galkin、R. A. Cherkasov

  DOI：10.1023/b:rugc.0000042422.61124.b3

  日期：2004.6

  alpha-Aminophosphoryl compounds of the phosphonate, phosphine oxide, and alpha,omega-bis(phosphine oxide) series and some of their thiophosphoryl analogs were synthesized. Potentiometric measurements of the pK(a) of the conjugate acids revealed an insignificant effect of variation of substituents on the phosphorus, nitrogen, and alpha-carbon atoms on the basicity of the phosphorylated amines. The latter are weak bases. Organophosphorus groups decrease the basicity of the amines by almost 5 pK(a) units. The role of the hydrophobic effect and intramolecular H-bonding in the obtained substances was discussed.
• Reaction of Elemental (White) Phosphorus with (Alkoxymethyl)dialkylamines
  作者：E. K. Badeeva、S. S. Krokhina、B. E. Ivanov

  DOI：10.1023/b:rugc.0000015981.21117.9f

  日期：2003.9

  The reaction of elemental (white) phosphorus with (alkoxymethyl)dialkylamines in the presence of sodium alkoxide results in complete conversion of P-4 in proton-donor solvents only. P-31 NMR spectroscopy allowed detection of the initial formation of P-III compounds whose subsequent transformations primarily provide phosphinate and phosphonate structures. Under the reaction conditions, trialkyl phosphites further react with (alkoxymethyl)dialkylamines to form dialkyl (dialkylamino)methylphosphonates.